期刊文献+

转录因子Sox2在人肺癌中的表达及其临床意义 被引量:12

The expression of Transcription factor Sox2 in human lung cancer and its clinical significance
下载PDF
导出
摘要 目的通过观察干细胞转录因子Sox2在鳞癌中的表达,分析其表达情况与病理类型、分化程度和淋巴结转移等的相关性,探讨Sox2在肺癌中的临床意义。方法应用免疫组织化学方法检测48例已确诊的不同类型肺癌组织和10例正常肺组织病理标本中Sox2的表达水平。结果 Sox2蛋白在肺鳞癌组织中的阳性表达率为69%,在肺腺癌组织中表达为4.5%,在小细胞肺癌组织中表达为70%,正常组织中无表达,差异具有显著性。Sox2蛋白表达与患者的年龄、性别、分化程度、有无淋巴结转移无明显相关性。结论 Sox2在鳞癌中高表达,在腺癌中几乎不表达,可作为非小细胞肺癌鉴别诊断的辅助指标。 Objective To observe the stem cell transcription factor Sox2expression in lung neoplasms,analyze the correlation between the expression with histological type,degree of differentiation,lymph node metastasis and so on,and explore the clinical significance of Sox2.Methods Using immunohistochemical methods to detect the the Sox2expression level in 48cases which have been diagnosed with different types of lung cancer and 10cases of normal lung tissue specimens.Results The positive expression rate of Sox2is 69%in lung squamous cell carcinoma,4.7%in lung adenocarcinoma,70%in small cell lung cancer.There is no expression in normal tissues.The difference in histological type was significant.However,there is no significant correlation between Sox2with age,gender,degree of differentiation,lymph node metastasis.Conclusion Lung squamous cell carcinoma has higher Sox2expression and lung adenocarcinoma has almost no Sox2expression,suggesting that Sox2is helpful to differential diagnosis of non-small-cell lung carcinoma.
出处 《中国实验诊断学》 2013年第8期1437-1439,共3页 Chinese Journal of Laboratory Diagnosis
基金 吉林省科技发展计划项目资助课题(201015159)
关键词 SOX2 肺肿瘤 鳞癌 腺癌 小细胞癌 非小细胞肺癌 Sox2 lung neoplasms squamous cell carcinoma adenocarcinoma small cell carcinoma non-small-cell lung carcinoma
  • 相关文献

参考文献12

  • 1J emal A,Siegel R,Xu J, et al. Cancer statistics[-J]. CA Cancer J Clin, 2010,60,277. 被引量:1
  • 2Guhbay J,Collignon J,Koopman P,et al. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes[J]. Nature, 1990,346:245. 被引量:1
  • 3Wang Q, He W,Lu C,et al. Oct3/4 and sox2 are significantly as- sociated with an unfavorable clinical outcome in human esophage- al squamous cell carcinoma [-J]. Anticancer Res, 2009, 29 ( 4 ) : 1233. 被引量:1
  • 4Soullier S, Jay P, Poulat F, et al. Diversification pattern of the HMG and SOX family members during evolution [J]. J Mol Evo1,1999,48(5) :517. 被引量:1
  • 5Bowles J,SehePers G, KooPman P, et al. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators[J]. Dev Biol, 2000,227 (2) : 239. 被引量:1
  • 6Chen L C, Vural B, Ustaner Z, et al. Immunoreactivity to SOX 1 <2 ,-3 and ZIC2 antigens and correlation to survival in small cell lung cancer (SCLC) [J]. J Clin Oncol , 2004, ( 14)22 : 7159. 被引量:1
  • 7Lengerke C,Fehm T,Kuilh R,et al. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinorna[J]. BMC Cancer,2011,11:42. 被引量:1
  • 8顾晓荔..SOX2、SOX17及β-catenin在宫颈鳞癌组织中的表达及意义[D].郑州大学,2012:
  • 9Brcic L, Sherer CK,Shuai Y, et al. Morphologic and clinicopatho logic features of lung squamous cell carcinomas expressing Sox2 [J]. Am J Clin Pathol,2012,138(5) :712. 被引量:1
  • 10Chen S, Xu Y, Chen Y, et al. SOX2 gene regulates the transcrip- tional network of oncogenes and affects tumorigenesis of human lung cancer cells[J]. PLoS One,2012,7(5) :e36326. 被引量:1

二级参考文献11

  • 1Socinski MA, Stinchcombe TE. Duration of first-line chemotherapy in advanced non-small-cell lung cancer: less is more in the era of effective subsequent therapies [ J]. J Clin Oncol, 2007,25 (33) : 5155-5157. 被引量:1
  • 2Huntly BJ, GiUiland DG. Cancer biology: summing up cancer stem ceils [J]. Nature, 2005,435(7046) :1169-1170. 被引量:1
  • 3Zhang S, Balch C, Chan MW, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors [ J]. Cancer Res, 2008,68 ( 11 ) :4311-4320. 被引量:1
  • 4Takaishi S, Okumura T, Tu SP, et al. Identification of gastric cancer stem cells using the cell surface marker CD44 [ J]. Stem Cells, 2009,27 ( 5 ) : 1006 1020. 被引量:1
  • 5Pan J, Zhang Q,Wang Y, et al. 26S proteasome activity is downregulated in lung cancer stem-like cglls propagated in vitro [ J ]. PLoS One, 2010,5(10) :e13298. 被引量:1
  • 6Weiss MA. Floppy SOX: mutual induced fit in hmg (high-mobility group) box-DNA recognition [J]. Mol Endocfinol, 2001,15(3) : 353-362. 被引量:1
  • 7Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells [J]. Nat Rev Mol Cell Biol, 2005,6( 11 ) :872-884. 被引量:1
  • 8Iki K, Pour PM. Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model [ J ]. Pancreaf01ogy, 2006,6 (4) : 406-413. 被引量:1
  • 9Sanada Y, Yoshida K, Ohara M, et al. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components [ J ]. Pancreas,2006,32i2):164-170. 被引量:1
  • 10Tsukamoto T, Mizoshita T, Mihara M, et al. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes [ J ]. Histopathology, 2005,46 (6) :649-658. 被引量:1

共引文献6

同被引文献123

  • 1李秀娟,金春亭,范婕,李玉珍,李海军,刘军超.Oct4和Wnt1在食管鳞癌中的表达及其相关性[J].中国老年学杂志,2014,34(10):2631-2632. 被引量:2
  • 2杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:336
  • 3Sun Y, Zhang R, Wang M, et al. SOX2 autoantibodies as noninvasive serum biomarker for breast carcinoma[J]. Cancer Epidemiol Biomarkers Prev, 2012,21(11):2043-47. 被引量:1
  • 4Stolzenburg S, Rots M G, Beltran A S, et al. Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer[J]. Nucleic Acids Res, 2012,40(14):6725-40. 被引量:1
  • 5Chen Y, Shi L, Zhang L, et al. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer[J]. J Biol Chem, 2008,283(26):17969-78. 被引量:1
  • 6Sanada Y, Yoshida K, Ohara M, et al. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2:comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components[J]. Pancreas, 2006,32(2):164-70. 被引量:1
  • 7Gangemi R M, Griffero F, Marubbi D, et al. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity[J]. Stem Cells, 2009,27(1):40-8. 被引量:1
  • 8Lu Y, Futtner C, Rock J R, et al. Evidence that SOX2 overexpression is oncogenic in the lung[J]. PloS One, 2010,5(6):e11022. 被引量:1
  • 9Sholl L M, Long K B, Hornick J L. Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas[J]. Appl Immunohistochem Mol Morphol, 2010,18(1):55-61. 被引量:1
  • 10Bass A J, Watanabe H, Mermel C H, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas[J]. Nat Genet, 2009,41(11):1238-42. 被引量:1

引证文献12

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部